Skip to main content

Raiffeisen Bank International AG

Bank

Position in BMY — Bristol Myers Squibb Co

CIK 2044885 VIENNA, C4

Position in BMY

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$24,947,673
-$2,180,101 QoQ
Shares Held
432,969
-3.2% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#249
of 2,506 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Jun 30, 2026
CallValue
$1,591,752
CallShares
27,625
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Raiffeisen Bank International AG holds $427,125,963 across 9 Drug Manufacturers - General names. BMY ranks #7 (5.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 BMY
Bristol Myers Squibb Co
This page
432,969 $24,947,673

All Filings in BMY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,947,673 432,969
2026-06-30 $1,591,752 27,625
2026-03-31 $1,675,456 27,625
2026-03-31 $27,127,774 447,284
2025-12-31 $1,490,092 27,625
2025-12-31 $24,386,651 452,107
2025-09-30 $1,245,887 27,625
2025-09-30 $17,074,454 378,591
2025-06-30 $17,626,167 380,777
2025-03-31 $23,377,405 383,299
2024-12-31 $20,771,094 367,240